NDC 50102-130-01 - CHATEAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-130
- Requested NDC
- 50102-130-01
- Package NDCs from labels
- 50102-130-00, 50102-130-01, 50102-130-48, 50102-130-10, 50102-130-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHATEAL - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-130-03 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-03 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-130-00 | EA - Each | 50102-130 | dcb62401-8949-464e-ab16-85f9c6f4c40d | 1 | 2022-06-06 |
| 50102-130-01 | EA - Each | 50102-130 | b8bb767c-e280-45f7-828d-4a8aaae9c21c | 1 | 2013-02-13 |
| 50102-130-03 | EA - Each | 50102-130 | 61c25f8e-2546-4292-98d9-3172853ce2f1 | 1 | 2017-09-11 |
| 50102-130-10 | EA - Each | 50102-130 | 4a3fd139-d25f-40ed-939c-42f8b7d58d0e | 1 | 2017-09-11 |
| 50102-130-48 | EA - Each | 50102-130 | 1a4669e5-b979-4386-ba8b-04d4f4b7e28e | 1 | 2013-02-13 |
| 50102-130-90 | EA - Each | 50102-130 | 3536e405-15d6-482b-949b-31b922af726b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Julie | LEVONORGESTREL | Julie Products Inc. | 8fb303ec-3b6a-47ac-9ad9-83ab6f0d6ae8 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| ITHAPPENZ MORNING AFTER | LEVONORGESTREL | Aurohealth LLC | 5ee40793-0121-4b8f-b20d-3178bbe262e2 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| Julie | LEVONORGESTREL | Julie Products Inc. | 8d20510f-a4e8-4d4b-a96a-f0da91785833 | 2025-04-07 | Warnings | 5W7SIA7YZW |
| Econ Morning After | LEVONORGESTREL | Aurohealth LLC | 177daa65-2e7d-4ff4-887e-b927d6ed8825 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | LEADER/ CARDINAL HEALTH 110, INC. | c7d3a74e-37c4-4c49-861c-64ef363d5a53 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Fem Choice morning after | LEVONORGESTREL | Aurohealth LLC | 14051537-9d6c-4f73-a6e9-5eed554bbf65 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| AMAZON BASIC CARE LEVONORGESTREL | LEVONORGESTREL | Amazon.com Services LLC | 10ecae6f-386f-e199-e063-6294a90a680b | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Athentia Next | LEVONORGESTREL | Aurohealth LLC | 34e5aa53-3943-4e2f-93aa-b5a4d779a703 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| After Banger | LEVONORGESTREL | Aurohealth LLC | 791a2461-971c-4191-8905-5a449c600a49 | 2025-04-04 | Warnings | 5W7SIA7YZW |
| Dolishale | LEVONORGESTREL AND ETHINYL ESTRADIOL | Ingenus Pharmaceuticals, LLC | 036a15be-8c2e-4f65-b5dc-f333e2994d4a | 2025-04-01 | Boxed warning, Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
| NuvaRing | ETONOGESTREL AND ETHINYL ESTRADIOL | Advanz Pharma (US) Corp. | 19ef66d1-913f-49a8-a0a5-59b4e20322f5 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Junel 21 Day | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 8b82ad14-580c-4145-b825-dce849f95363 | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Etonogestrel/Ethinyl Estradiol | ETONOGESTREL AND ETHINYL ESTRADIOL | Prasco Laboratories | f0d80e01-f4f5-4b1a-bc9e-50a2bd4390b1 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Loestrin Fe 28 Day | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | Teva Women's Health LLC | f29ebcb5-7e65-4092-bfaa-f5ec026fc255 | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Morning After Pill | LEVONORGESTREL | Cadence Health Inc | fc5d29bb-4a4b-e61e-e053-6394a90a8a62 | 2025-02-14 | Warnings | 5W7SIA7YZW |
| LUIZZA 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Xiromed LLC | b1c3e33d-ec95-cd89-7ad9-36994c802a1f | 2025-02-12 | Warnings, Adverse reactions | 423D2T571U |
| EluRyng | ETONOGESTREL AND ETHINYL ESTRADIOL | Amneal Pharmaceuticals LLC | c6c8512d-b258-4be5-8c2f-0f1893f198b9 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| My Way | LEVONORGESTREL | Proficient Rx LP | f2354b0c-dda4-4eb4-93f3-b2d57856a948 | 2025-01-01 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Thirty Madison Inc. | 6933ae19-4c8f-49a2-96c5-9cdf37ee5824 | 2024-12-30 | Warnings | 5W7SIA7YZW |
| Junel 21 Day | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Proficient Rx LP | 56e91ad4-f31b-494d-9e75-6dd4f396779c | 2024-12-01 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.